Literature DB >> 12459408

Thalidomide-associated deep vein thrombosis and pulmonary embolism.

Charles L Bennett1, Glen T Schumock, Apurva A Desai, Hau C Kwaan, Dennis W Raisch, Rebecca Newlin, Walter Stadler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12459408     DOI： 10.1016/s0002-9343(02)01300-1

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  14 in total

Review 1.  Management of interstitial lung disease associated with connective tissue disease.

Authors:  Stephen C Mathai; Sonye K Danoff
Journal:  BMJ       Date:  2016-02-24

2.  Phase I trial of thalidomide and interleukin-2 in patients with metastatic renal cell carcinoma.

Authors:  Thomas Olencki; Sareena Malhi; Tarek Mekhail; Robert Dreicer; Paul Elson; Laura Wood; Ronald M Bukowski
Journal:  Invest New Drugs       Date:  2006-07       Impact factor: 3.850

3.  Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial.

Authors:  J N Gordon; T M Trebble; R D Ellis; H D Duncan; T Johns; P M Goggin
Journal:  Gut       Date:  2005-04       Impact factor: 23.059

Review 4.  Bisphosphonates and nonhealing femoral fractures: analysis of the FDA Adverse Event Reporting System (FAERS) and international safety efforts: a systematic review from the Research on Adverse Drug Events And Reports (RADAR) project.

Authors:  Beatrice J Edwards; Andrew D Bunta; Joseph Lane; Clarita Odvina; D Sudhaker Rao; Dennis W Raisch; June M McKoy; Imran Omar; Steven M Belknap; Vishvas Garg; Allison J Hahr; Athena T Samaras; Matthew J Fisher; Dennis P West; Craig B Langman; Paula H Stern
Journal:  J Bone Joint Surg Am       Date:  2013-02-20       Impact factor: 5.284

5.  A tale of two citizens: a State Attorney General and a hematologist facilitate translation of research into US Food and Drug Administration actions--a SONAR report.

Authors:  Brian Chen; John Restaino; LeAnn Norris; Sudha Xirasagar; Zaina P Qureshi; June M McKoy; Isaac S Lopez; Alyssa Trenery; Alanna Murday; Adam Kahn; Donald R Mattison; Paul Ray; Oliver Sartor; Charles L Bennett
Journal:  J Oncol Pract       Date:  2012-08-14       Impact factor: 3.840

Review 6.  Thalidomide analogues as anticancer drugs.

Authors:  Jeanny B Aragon-Ching; Haiqing Li; Erin R Gardner; William D Figg
Journal:  Recent Pat Anticancer Drug Discov       Date:  2007-06       Impact factor: 4.169

Review 7.  Thalidomide and its derivatives: emerging from the wilderness.

Authors:  J N Gordon; P M Goggin
Journal:  Postgrad Med J       Date:  2003-03       Impact factor: 2.401

8.  Arterial thrombosis and thalidomide.

Authors:  Mustafa Goz; M Nesimi Eren; Omer Cakir
Journal:  J Thromb Thrombolysis       Date:  2008-04       Impact factor: 2.300

Review 9.  Thromboprophylaxis guidelines in cancer with a primary focus on ambulatory patients receiving chemotherapy: a review from the Southern Network on Adverse Reactions (SONAR).

Authors:  Whitney D Maxwell; Charles L Bennett
Journal:  Semin Thromb Hemost       Date:  2012-10-30       Impact factor: 4.180

Review 10.  New therapies in multiple myeloma.

Authors:  F Merchionne; F Perosa; F Dammacco
Journal:  Clin Exp Med       Date:  2007-10-03       Impact factor: 3.984
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.